The breast fibroblast derived IGF-I signature was able to stratify patients with lung cancer (Bhattacharjee dataset) into two groups with significantly different rates of survival (overall survival with P = 0.043 and disease free survival with P = 0.022, data not shown). Here, IGF1 is linked to lung cancer.